Effects of an External Oral Irrigation Device on Patients With Dry Mouth

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Completed
CT.gov ID
NCT04901507
Collaborator
Voutia (Other)
25
1
1
11.3
2.2

Study Details

Study Description

Brief Summary

The purpose of this research study is to test the effectiveness of treating dry mouth through water rehydration using this extra oral water pump/irrigation device.

Condition or Disease Intervention/Treatment Phase
  • Device: The Voutia System
N/A

Detailed Description

Dry mouth causes difficulty with chewing, swallowing, speech, and increases the risk dental cavities. It also can cause discomfort in the mouth, and a loss of general quality of life. The oral irrigation device supplies a small amount of water to participant's mouth through a small tube that is placed in the corner of the mouth throughout the time participants wear it.

In this study, participants will be asked to:
  1. Visit the dental school clinic two (2) times for study visits.

  2. Wear the oral irrigation device as directed by the investigator.

  3. Keep notes at home.

  4. Answer survey questions during both dental visits about dry mouth symptoms.

  5. Give permission for the researchers to collect information about medications or health conditions that contribute to dry mouth from participant's medical records.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of an External Oral Irrigation Device on Patients With Dry Mouth
Actual Study Start Date :
May 20, 2021
Actual Primary Completion Date :
Apr 28, 2022
Actual Study Completion Date :
Apr 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: The Voutia System

The Voutia System oral irrigation device

Device: The Voutia System
Participants will wear the Voutia System oral irrigation device continuously through the day and night, removing for cleaning and if otherwise necessary, but not for time extending beyond six-eight hours.
Other Names:
  • Oral irrigation device
  • Outcome Measures

    Primary Outcome Measures

    1. Change in oral health related quality of life (OHRQoL) [Baseline to 4 - 6 weeks]

      OHRQoL will be assess using the Oral Health Impact Profile (OHIP-14). The OHIP-14 scores can range from 0 to 56 and are calculated by summing the ordinal values for the 14 items on the scale. Higher OHIP-14 scores indicate worse and lower scores indicate better OHRQol

    2. Change in oral health related quality of life - dry mouth specific (OHRQoL-XI) [Baseline to 4 - 6 weeks]

      OHRQoL-XI will be assessed using the Xerostomia Inventory (XI), an 11-item summated rating scale which combines the responses to 11 individual items into a single continuous scale score which represents the severity of chronic xerostomia. Scores range from 11 to 55 with higher scores represent more severe symptoms.

    3. Change in oral dryness [Baseline to 4 - 6 weeks]

      Clinical Oral Dryness Score (CODS) conducted during the clinical exam assesses ten key features of dry mouth and allocates one point for each feature. The total score ranges from 0 to 10 with higher scores indicating more severe dry mouth.

    4. Clinical changes in saliva flow [Baseline to 4 - 6 weeks]

      Data on routine saliva testing as performed as standard of care for patients suspected to have reduced salivary flow will be compared before and after use of the device.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients who report xerostomia (dry mouth) and are diagnosed after testing with hypofunctioning salivary glands
    Exclusion Criteria:
    • Patient who after testing do not exhibit salivary hypofunction

    • Children

    • Patient with limited English proficiency

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Virginia Commonwealth University Richmond Virginia United States 23298

    Sponsors and Collaborators

    • Virginia Commonwealth University
    • Voutia

    Investigators

    • Principal Investigator: Susie Goolsby, DDS, MSHA, Virginia Commonwealth University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Virginia Commonwealth University
    ClinicalTrials.gov Identifier:
    NCT04901507
    Other Study ID Numbers:
    • HM20021188
    First Posted:
    May 25, 2021
    Last Update Posted:
    May 2, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 2, 2022